Had a look at the figures in particular sales.
They have only recently employed a further 2 Business development managers(Salesman) in the last 3 months giving 3 in total. So will take time for the new Salesman to find their feet.
The bookings for hardware for the quarter Dec 23 was $308k which was up from $239k or 28% which was promising.
Qualified opportunities at Dec 23 was 347k compared to Sep 23 260k up 33% also promising.
New licences YTD Dec 23 - 510 YTD Sep 23- 470 up 8.5%.
Also in cashflow it was quoted -
"The reduction in operating expenses and growth in sales is expected to
generate a positive net cash flow ".
They have entered into the agreement with Morph Clinical to further expand product lines and obtained a loan facility from NAB so they are looking to the future.
Overall the next 3-6 months will tell how they are tracking especially in sales.
- Forums
- ASX - By Stock
- Ann: December 2023 Quarterly Update and Appendix 4C
Had a look at the figures in particular sales.They have only...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add JTL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online